Table 7.
BMI |
Luminal A comparison |
Luminal B |
Her2+ |
TN |
||||||
---|---|---|---|---|---|---|---|---|---|---|
n | n | OR | 95% CI | n | OR | 95% CI | n | OR | 95% CI | |
UW | 34 | 9 | 1.00 | Reference | 7 | 1.00 | Reference | 16 | 1.00 | Reference |
NW | 322 | 118 | 1.38 | 0.65–2.97 | 74 | 1.12 | 0.48–2.62 | 128 | 0.85 | 0.45–1.58 |
OW | 143 | 42 | 1.11 | 0.49–2.50 | 26 | 0.88 | 0.35–2.20 | 66 | 0.98 | 0.51–1.90 |
OB | 30 | 8 | 1.01 | 0.35–2.94 | 4 | 0.65 | 0.17–2.43 | 13 | 0.92 | 0.38–2.22 |
Subtotal | 529 | 177 | 111 | 223 | ||||||
Premenopausal | ||||||||||
UW | 21 | 6 | 1.00 | Reference | 4 | 1.00 | Reference | 4 | 1.00 | Reference |
NW | 155 | 63 | 1.42 | 0.55–3.69 | 27 | 0.92 | 0.29–2.87 | 47 | 1.59 | 0.52–4.87 |
OW | 49 | 17 | 1.21 | 0.42–3.51 | 13 | 1.39 | 0.41–4.77 | 24 | 2.57 | 0.79–8.33 |
OB | 9 | 2 | 0.78 | 0.13–4.62 | 2 | 1.17 | 0.18–7.56 | 11 | 6.42** | 1.61–25.64 |
Subtotal | 234 | 88 | 46 | 86 | ||||||
Postmenopausal | ||||||||||
UW | 13 | 3 | 1.00 | Reference | 3 | 1.00 | Reference | 12 | 1.00 | Reference |
NW | 167 | 55 | 1.43 | 0.39–5.19 | 47 | 1.22 | 0.33–4.46 | 81 | 0.53 | 0.23–1.20 |
OW | 94 | 25 | 1.15 | 0.31–4.36 | 13 | 0.60 | 0.15–2.39 | 42 | 0.48 | 0.20–1.15 |
OB | 21 | 6 | 1.24 | 0.26–5.83 | 2 | 0.41 | 0.06–2.81 | 2 | 0.10** | 0.02–0.54 |
Subtotal | 295 | 89 | 65 | 137 |
OR, odds ratio; CI, confidence interval; BMI, body mass index; Her2, human epidermal growth factor receptor 2; TN, triple-negative; UW, underweight; NW, normal weight; OW, overweight; OB, obese.
*P < 0.05; **P < 0.01 vs the UW group.
Reference: luminal A is regarded as the reference as the most common subtype.